Kaspi.kz: Turkey Expansion Promises Large Upside, but Near-Term Margin Pressure Tempers Conviction

What happened

Kaspi.kz trades at a depressed forward P/E of 7.6x despite its dominant super-app ecosystem in Kazakhstan and a proven playbook it aims to replicate in Turkey. The Seeking Alpha article highlights that the Turkish venture, while currently dilutive, could unlock outsized revenue growth and margin recovery as fintech products scale, implying a $163 price target (over 75% upside). However, the DeepValue master report tempers this optimism by flagging rising deposit funding costs (14.3% in Q1 2026) and insider selling activity, with its base case valuation at just $95. Near-term profitability remains under pressure, as Q1 2026 net income fell ~1% YoY despite 31% revenue growth, and the Turkish unit Hepsiburada is only operating around EBITDA breakeven by design. The bull case depends on stabilization of Kazakhstan deposit costs and evidence that Hepsiburada can maintain breakeven while scaling, conditions that are not yet proven.

Implication

The Seeking Alpha price target of $163 implies flawless execution in Turkey and a rapid normalization of Kazakhstan margins, a scenario the DeepValue report assigns only a 25% probability. Near-term risks are concentrated in deposit funding cost trends (up 220 bps YoY) and the potential for Hepsiburada to drift from breakeven, which would convert the expansion into a structural earnings drag. Insider selling by a director in May-June 2026 further raises concerns about management's true conviction in the near-term outlook. Investors should monitor Q2 2026 results for signs that deposit costs have peaked and that Hepsiburada's GMV growth is translating into sustained unit economics. Until these milestones are met, the stock likely remains range-bound between the $78 entry point and the $105 trim level identified in the DeepValue analysis.

Thesis delta

The new article introduces a highly bullish valuation argument based on the Turkish playbook's long-term potential, shifting the upside scenario well above prior estimates. However, the DeepValue report's emphasis on near-term headwinds—deposit cost pressure, margin compression, and insider selling—raises the execution bar, making the bull case contingent on rapid resolution of funding costs and no deterioration in Hepsiburada's breakeven stance.